Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-248,497
Closed -$3.65M 952
2025
Q3
$3.65M Buy
248,497
+36,542
+17% +$372K 0.13% 201
2025
Q2
$2.08M Buy
211,955
+71,649
+51% +$593K 0.08% 309
2025
Q1
$1.02M Buy
140,306
+45,812
+48% +$401K 0.05% 470
2024
Q4
$739K Buy
+94,494
New +$778K 0.03% 532

Other funds holding ETNB

Hennion & Walsh Asset Management's ETNB Position: Q4 2025 in Review

Hennion & Walsh Asset Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 248,497 shares — an estimated $3.65M sold.

Hennion & Walsh Asset Management first reported a position in ETNB in Q4 2024 and held it in 4 quarters. The position peaked at $3.65M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Hennion & Walsh Asset Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 248,497 89bio shares in Q4 2025, an estimated $3.65M.
  • Hennion & Walsh Asset Management first reported a position in 89bio in Q4 2024 and held it in 4 quarters.
  • Hennion & Walsh Asset Management's 89bio position peaked at $3.65M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2025, filed 14 Jan 2026.